Physician profile
Daniel Fortes
NPI 1124037486
$22,979.03
in general payments reported to CMS, 2019-2025
39 companies · $12K in 2025
The $12K reported for 2025 was more than what 91% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,342 · 2020: $344 · 2021: $2,506 · 2022: $1,291 · 2023: $810 · 2024: $2,734 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,082 · Food and Beverage: $3,380 · Education: $3,271 · Travel and Lodging: $2,049 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Honoraria: $700 · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,082.20 |
| Food and Beverage | $3,379.62 |
| Education | $3,270.69 |
| Travel and Lodging | $2,048.84 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Honoraria | $700.00 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,816.56 | 2019-2025 | Da Vinci Surgical System |
| Hologic Sales and Service, LLC | $5,377.22 | 2025 | Coolseal Generator |
| Cytyc Surgical Products, LLC | $805.14 | 2025 | Coolseal Generator |
| Cook Incorporated | $700.00 | 2024 | |
| Ethicon INC. | $629.14 | 2019-2021 | |
| C. R. Bard, INC. & Subsidiaries | $464.50 | 2019 | |
| Zimmer Biomet Holdings, INC. | $373.91 | 2021 | |
| Medtronic, INC. | $360.49 | 2021-2022 | |
| Davol INC. | $305.27 | 2019-2025 | Arista |
| Covidien Lp | $305.16 | 2019-2020 | |
| Kls-Martin L.P. | $296.40 | 2019 | |
| Novartis Pharmaceuticals Corporation | $279.77 | 2022-2024 | |
| Regeneron Healthcare Solutions, INC. | $262.84 | 2022-2025 | Libtayo |
| Atricure, INC. | $262.05 | 2019-2022 | |
| On Target Laboratories, INC | $182.05 | 2025 | Cytalux |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $176.27 | 2023-2025 | Keytruda |
| Astrazeneca Pharmaceuticals Lp | $163.13 | 2022-2025 | Tagrisso |
| Galvanize Therapeutics, INC | $149.27 | 2023 | Aliya System |
| Cook Medical LLC | $126.58 | 2020 | |
| Stryker Corporation | $117.91 | 2019 | |
| Ethicon US, LLC | $99.33 | 2019-2025 | Vistaseal, Echelon Endopath |
| E.R. Squibb & Sons, L.L.C. | $81.06 | 2022-2024 | |
| Baxter Healthcare | $80.25 | 2023 | Hillrom - Life 2000 Ventilation System |
| Celgene Corporation | $78.71 | 2022 | |
| Coherus Oncology, INC. | $50.02 | 2023-2024 | |
| Adaptive Biotechnologies Corporation | $48.56 | 2023-2024 | Clonoseq |
| Seagen INC. | $42.90 | 2023 | Tukysa |
| Exelixis INC. | $42.56 | 2024 | Cabometyx |
| Daiichi Sankyo INC. | $41.03 | 2021-2024 | Enhertu |
| Genentech USA, INC. | $40.27 | 2024-2025 | Tecentriq, Alecensa, Itovebi |
| Becton, Dickinson and Company | $38.12 | 2024 | Arista Ah Flexitip |
| Tersera Therapeutics LLC | $26.69 | 2025 | Zoladex |
| Eisai INC. | $26.50 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.65 | 2021 | |
| Janssen Biotech, INC. | $23.38 | 2024 | Rybrevant |
| Pfizer INC. | $23.15 | 2024 | |
| Glaxosmithkline, LLC. | $22.38 | 2021 | |
| Karyopharm Therapeutics INC. | $21.69 | 2024 | Xpovio |
| Alexion Pharmaceuticals, INC. | $15.12 | 2024 | Ultomiris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Fortes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.